Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

UCB Pharma750 enrolled

Overview

Patients will be followed up for max 18 months. Information on the Adverse Events and potential misuse or abuse of Xyrem ® will be collected.

Study Type

OBSERVATIONAL

Enrollment

750

Conditions

Narcolepsy

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who received Xyrem ® on prescription Exclusion Criteria: * No limitations

Locations (41)

Graz, Austria

Outcomes

Primary Outcomes

Evaluation of risk for development adverse events, withdrawal syndrome and potential for dependence, abuse, overdose and misuse of Xyrem®. Obtaining information about adherence to Xyrem® prescribing information regarding indication and dosage.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.